Ulcerative Colitis (UC) Completed Phase 2 Trials for Tralokinumab (DB12169)

Also known as: UC - Ulcerative Colitis / Colitis, Ulcerative (UC) / Ulcerative Colitis / Colitis, Ulcerative / Colitis,Ulcerative / Colitis Ulcerative / Proctocolitis, idiopathic / Idiopathic proctocolitis / UC / Ulcerative colitis, unspecified

DBCOND0052192 (Ulcerative Colitis (UC))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01482884Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative ColitisTreatment